8-K - C4 Therapeutics, Inc. - 1.01 / 7.01 / 9.01
Filed: 2026-04-09 AccNo: 0001628280-26-024336 Size: 4 MB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Filed: 2026-04-09 AccNo: 0001628280-26-024336 Size: 4 MB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Filed: 2026-04-09 AccNo: 0001174947-26-000467 Size: 469 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits